Citeline and Norstella are merging to form a global pharmaceutical technology company

– Citeline and Norstella complete their merger to form a global pharmaceutical technology company of 5,000 million dollars

With more than 1,600 employees worldwide, the new organization is now one of the largest providers of pharmaceutical intelligence solutions in the market

YARDLEY, Pa., November 1, 2022/PRNewswire/ — Norstellaworld leader with integral solutions that facilitate access to therapies that save lives for patients, has announced the finalization of its fusion with Citeline (previously Pharma Intelligence), líder en el espacio de inteligencia de ensayos clinícos.

Al cierre del trato, the global company of 5,000 million dollars is now one of the largest providers of pharmaceutical intelligence solutions in the world in the market, with more than 1,600 employees in the five brands that make up Norstella: Evaluate, MMIT, Panalgo, The Dedham Group y ahora Citeline.

This merger will allow Norstella to prioritize rapid innovation to help guide life science companies through the entire medication development process so that patients can access therapies more quickly.

“Creemos que el acceso del paciente begins with the identification of the needs not satisfied and no term hasta que el paciente tiene una terapia disponible”, he highlighted Mike Gallupconsejero delegado de Norstella. “As the industry advances to highly specific therapies centered on smaller patient populations, our clients need solutions that offer actionable answers to critical commercial questions to help bring medications to the market more quickly and, ultimately, help patients a recibir tratamiento antes”.

From the process of clinical discovery to commercialization, the manufacturers of pharmaceutical products are overwhelmed with data and questions about the application of data from the real world, the understanding of the disease burden, the communication of the clinical efficacy of a drug, the the revelation of an unexpectedly positive clinical result or the quantification of the consequence of a therapy retrasada al mercado.

As a combined organization, Norstella’s solutions will allow pharmaceutical interested parties to identify clinical needs that are not satisfied early, build clinical trials with informed final points that support later reimbursement decisions and accurately identify patients eligible for clinical trials . Un poderoso ejemplo de esto es la plataforma Instant Health Data (IHD) de Panalgoque puede ingerir datos de ensayos clínicos y del mundo real de Citeline, datos de laboratory de patients, policies y restrictions de MMIT, y datos de vías clínicas y evidencia del mundo real de The Dedham Group, todo de los cuales se pueden para respond quickly preguntas clave relacionadas con el viaje del paciente, el reembolso del pagador y la seguridad y eficacia de la terapia.

“This union is an opportunity for both Citeline and Norstella to advance in their shared mission of making therapies available to patients who need them,” he explained. Jay Nadlerpresidente ejecutivo de Norstella y Ramsey Hashem, consejero delegado de Citeline. “Sentimos la urgencia de tener un impacto y creemos que podemos aportar innovación que cambiará la vida de los pacientes”.

Gallup added: “Una filosofia clave en Norstella es innovar en asociación con nuestros clientes; continuaremos preguntándoles dónde hay una brecha y cómo podemos cerrarla. Juntos, nuestro objetivo es crear un mercado de atención medica que sea más innovator y accesible para todos”.

About de Norstella

At Norstella, our mission is simple: ayudar a los pacientes a obtener acceso a terapias que salvan vidas. Norstella consta de varias organizaciones destacadas (Citeline, Evaluate, MMIT, Panalgo y The Dedham Group) que se han unido para oferer una gama completa de solutions y servicios de consultoría pharmaceutica. As an organization, Norstella ofrece a los clientes de la ciencias de la life the tools and the experience adequadas to navigate through the complexities in each step of the life cycle of the drug development, from the pipeline to the patient. For more information, visit Norstella y síganos en LinkedIn.

About Citeline

Citeline (previously Pharma Intelligence) impulse and a complete set of complementary offers of commercial intelligence to satisfy the changing needs of life sciences professionals to accelerate the connection of treatments with patients and patients with treatments. Estas solutions y servicios centrados en el paciente entregan y analisan datos que se utilizán para impulsar decisión clinicas, commerciales y regulatorias y crear opportunidades de crecimiento en el mundo real.

Nuestros equipos globales de analistas, journalistis y consultores se mantiten al tanto de las industrias pharmaceutica, biomédica y de tecnologia medica, cubriéndolo todo con conocimientos de experts: enfermedades claves, ensayos clínicos, investigation y desarrollo de medicamentos y approbaciones, prognosticos de mercado y más . Para obtener más información sobre uno de los partners de ciencias de la vida más confiable del mundo, visite Citeline.

Contactos para los medios

NorstellaMelody Udell | directora de Comunicación +1 312-618-5968 | melody.udell@norstella.com

CitelineBlair Dawson | vice president of Communication and Implication with the employee +1 919-413-4616 | blair.dawson@informa.com

View original content: enlace

Leave a Comment

Your email address will not be published. Required fields are marked *